E/e' in relation to outcomes in ST‐elevation myocardial infarction
Sarah Tai(Ministry of Health), Anders Sahlén(National Heart Centre Singapore), See Hooi Ewe(National Heart Centre Singapore), Wei Ren Lau(Ministry of Health), Jonathan Yap(National Heart Centre Singapore), Jiang Ming Fam(Duke-NUS Medical School), Mark Y. Chan(National University Heart Centre Singapore), Mohammed Amanullah(National Heart Centre Singapore), Nadira Hamid(Abbott Northwestern Hospital), Zee Pin Ding(National Heart Centre Singapore), Fei Gao(Duke-NUS Medical School), Khung Keong Yeo(SingHealth)
Cited by 7
Related Papers
The global burden of metabolic disease: Data from 2000 to 2019
|Cell Metabolism|2023|777
The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease
|Thrombosis and Haemostasis|2020|334
Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals
|The Journal of Clinical Endocrinology & Metabolism|2022|306
Adherence to Guideline‐Recommended Therapy Is Associated With Decreased Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients With Peripheral Arterial Disease
|Journal of the American Heart Association|2014|243
The Association of Methamphetamine Use and Cardiomyopathy in Young Patients
|The American Journal of Medicine|2007|203